ea0086p245 | Neuroendocrinology and Pituitary | SFEBES2022
Miler Emma
, McMurray Susanne
, McArdle Nicholas
, Ahluwalia Rupa
, Chipchase Allison
Background: The suitability of serum insulin-like growth factor 1 (IGF-1) reference ranges (RR) used locally (manufacturer-derived), were raised as a clinical concern. IGF-1 levels above the RR were reported in patients displaying no clinical signs or symptoms of acromegaly, and in whom growth hormone suppression tests were negative. No analytical issue was evident, and quality performance indicators were satisfactory.Methods: A review of all serum IGF-1...